Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Armata Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q1 2021
- Shares held
- 1.16M
- −18.6K (−1.6%) vs. Q1 2021
- Total value
- $4.59M
- −$1.03M (−18.3%) vs. Q1 2021
- New holders
- 1
- 4 more added
- Sold out
- 3
- 7 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 53 | $32.3M |
| Q1 2026 | 45 | $40.2M |
| Q4 2025 | 36 | $7.85M |
| Q3 2025 | 28 | $2.27M |
| Q2 2025 | 29 | $1.40M |
| Q1 2025 | 26 | $1.08M |
| Q4 2024 | 24 | $2.57M |
| Q3 2024 | 24 | $3.28M |
| Q2 2024 | 23 | $3.86M |
| Q1 2024 | 24 | $5.93M |
| Q4 2023 | 25 | $4.17M |
| Q3 2023 | 23 | $3.85M |
| Q2 2023 | 22 | $1.35M |
| Q1 2023 | 23 | $2.06M |
| Q4 2022 | 26 | $1.61M |
| Q3 2022 | 20 | $5.73M |
| Q2 2022 | 19 | $5.25M |
| Q1 2022 | 20 | $6.61M |
| Q4 2021 | 17 | $7.25M |
| Q3 2021 | 20 | $4.32M |
| Q2 2021 | 21 | $4.59M |
| Q1 2021 | 23 | $5.62M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Armata Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 58 | $0 | 0.00% | −928−94.1% | Reduced |
| Wells Fargo & Company | 49 | $0 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 45 | $0 | 0.00% | −5−10.0% | Reduced |
| TCI Wealth Advisors, Inc. | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 571 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 484 | $2.00K | 0.00% | 00.0% | Unchanged |
| Sandy Spring Bank | 1,082 | $4.00K | 0.00% | +711+191.6% | Added |
| UBS Group AG | 1,466 | $6.00K | 0.00% | −4,551−75.6% | Reduced |
| BlackRock Inc. | 2,001 | $8.00K | 0.00% | −38,447−95.1% | Reduced |
| Morgan Stanley | 1,992 | $8.00K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 10,055 | $40.0K | 0.00% | −5,346−34.7% | Reduced |
| Geode Capital Management, LLC | 10,188 | $40.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,873 | $43.0K | 0.00% | −10,433−49.0% | Reduced |
| SeaCrest Wealth Management, LLC | 13,500 | $54.0K | 0.01% | 00.0% | Unchanged |
| Synovus Financial Corp | 23,060 | $91.0K | 0.00% | +23,060 | New |
| Edgewood Management LLC | 50,000 | $198.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 113,400 | $450.0K | 0.01% | +65,000+134.3% | Added |
| Renaissance Technologies LLC | 116,696 | $463.0K | 0.00% | −7,120−5.8% | Reduced |
| Vanguard Group Inc | 167,378 | $665.0K | 0.00% | +91,782+121.4% | Added |
| Bank of America Corp | 634,097 | $2.52M | 0.00% | +1530.0% | Added |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −129,956−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,444−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −109−100.0% | Sold out |